Skip to content

Effectiveness of a Digital Prescription-Based Intervention to Promote Influenza Vaccination among Patients with Chronic Obstructive Pulmonary Disease

Effectiveness of a Digital Prescription-Based Intervention to Promote Influenza Vaccination among Patients with Chronic Obstructive Pulmonary Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127605
Enrollment
Unknown
Registered
2026-07-02
Start date
2026-07-03
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

Intervention Group:Physicians issued standardized vaccine education prescriptions and integrated vaccination recommendations into routine clinical practice, thereby standardizing and routinizing vacci
Control Group:Routine clinical practice model

Sponsors

Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Previously diagnosed with COPD; 2. Aged 35 years or above at the time of signing informed consent; 3. Not vaccinated against influenza in the current year; 4. The patient with COPD agrees to participate in the project; 5. Has continuously resided in the study area for at least 6 months and has no plan for long-term absence or relocation within the next 6 months, to ensure completion of follow-up; 6. Able to participate in the study according to the study protocol; 7. Willing and able to sign the electronic informed consent form to participate in the trial.

Exclusion criteria

Exclusion criteria: 1. Has cognitive impairment and is unable to correctly understand the health education materials or complete the surveys required for the study; 2. Is currently participating in another intervention that may affect the outcomes of this study; 3. Has contraindications to influenza vaccination; 4. Has a severe illness or is at the end stage of life; 5. Is considered unsuitable for participation in this study for other reasons.

Design outcomes

Primary

MeasureTime frame
Influenza vaccination rate;

Secondary

MeasureTime frame
Healthcare service utilization;Outcomes related to acute exacerbations;All-cause and disease-specific outcomes;Cardiovascular composite outcomes;Vaccine hesitancy;

Countries

China

Contacts

Public ContactHe Ping

Peking University

phe@pku.edu.cn+86 10 82805709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026